71 related articles for article (PubMed ID: 24464706)
1. Molecular modeling of ABC transporter system - permease proteins from Microcoleus chthonoplastes PCC 7420 for effective binding against secreted aspartyl proteinases in Candida albicans - a therapeutic intervention.
Manivannan P; Muralitharan G
Interdiscip Sci; 2014 Mar; 6(1):63-70. PubMed ID: 24464706
[TBL] [Abstract][Full Text] [Related]
2. Insights into the selective inhibition of Candida albicans secreted aspartyl protease: a docking analysis study.
Pranav Kumar SK; Kulkarni VM
Bioorg Med Chem; 2002 Apr; 10(4):1153-70. PubMed ID: 11836127
[TBL] [Abstract][Full Text] [Related]
3. Candida albicans secreted aspartyl proteinases.
Hube B
Curr Top Med Mycol; 1996 Dec; 7(1):55-69. PubMed ID: 9504059
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, inhibition studies, and molecular modeling of pepstatin analogues addressing different secreted aspartic proteinases of Candida albicans.
Cadicamo CD; Mortier J; Wolber G; Hell M; Heinrich IE; Michel D; Semlin L; Berger U; Korting HC; Höltje HD; Koksch B; Borelli C
Biochem Pharmacol; 2013 Apr; 85(7):881-7. PubMed ID: 23262278
[TBL] [Abstract][Full Text] [Related]
5. Revealing anti-fungal potential of plant-derived bioactive therapeutics in targeting secreted aspartyl proteinase (SAP) of
Dhanasekaran S; Pushparaj Selvadoss P; Sundar Manoharan S; Jeyabalan S; Devi Rajeswari V
J Biomol Struct Dyn; 2024; 42(2):710-724. PubMed ID: 37021476
[No Abstract] [Full Text] [Related]
6. Functional Dependence between Septal Protein SepJ from Anabaena sp. Strain PCC 7120 and an Amino Acid ABC-Type Uptake Transporter.
Escudero L; Mariscal V; Flores E
J Bacteriol; 2015 Aug; 197(16):2721-30. PubMed ID: 26078444
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of Candida albicans secreted aspartyl proteinase in human vulvovaginal candidiasis.
Lian CH; Liu WD
Mycoses; 2007 Sep; 50(5):383-90. PubMed ID: 17714358
[TBL] [Abstract][Full Text] [Related]
8. Effect of antimycotic agents on the activity of aspartyl proteinases secreted by Candida albicans.
Schaller M; Krnjaic N; Niewerth M; Hamm G; Hube B; Korting HC
J Med Microbiol; 2003 Mar; 52(Pt 3):247-249. PubMed ID: 12621090
[TBL] [Abstract][Full Text] [Related]
9. Multiplicity of genes encoding secreted aspartic proteinases in Candida species.
Monod M; Togni G; Hube B; Sanglard D
Mol Microbiol; 1994 Jul; 13(2):357-68. PubMed ID: 7984113
[TBL] [Abstract][Full Text] [Related]
10. The putative ABC transporter encoded by the orf19.4531 plays a role in the sensitivity of Candida albicans cells to azole antifungal drugs.
Jiang L; Xu D; Chen Z; Cao Y; Gao P; Jiang Y
FEMS Yeast Res; 2016 May; 16(3):. PubMed ID: 26975389
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of the N-terminal nucleotide binding domain of an ABC drug transporter of Candida albicans: uncommon cysteine 193 of Walker A is critical for ATP hydrolysis.
Jha S; Karnani N; Dhar SK; Mukhopadhayay K; Shukla S; Saini P; Mukhopadhayay G; Prasad R
Biochemistry; 2003 Sep; 42(36):10822-32. PubMed ID: 12962507
[TBL] [Abstract][Full Text] [Related]
12. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
13. CAN1, a gene encoding a permease for basic amino acids in Candida albicans.
Sychrová H; Souciet JL
Yeast; 1994 Dec; 10(12):1647-51. PubMed ID: 7725800
[TBL] [Abstract][Full Text] [Related]
14. Functional characterization of N-terminal nucleotide binding domain (NBD-1) of a major ABC drug transporter Cdr1p of Candida albicans: uncommon but conserved Trp326 of Walker B is important for ATP binding.
Rai V; Shukla S; Jha S; Komath SS; Prasad R
Biochemistry; 2005 May; 44(17):6650-61. PubMed ID: 15850398
[TBL] [Abstract][Full Text] [Related]
15. CaALK8, an alkane assimilating cytochrome P450, confers multidrug resistance when expressed in a hypersensitive strain of Candida albicans.
Panwar SL; Krishnamurthy S; Gupta V; Alarco AM; Raymond M; Sanglard D; Prasad R
Yeast; 2001 Sep; 18(12):1117-29. PubMed ID: 11536334
[TBL] [Abstract][Full Text] [Related]
16. Dissimilar attenuation of Candida albicans virulence properties by human immunodeficiency virus type 1 protease inhibitors.
Gruber A; Berlit J; Speth C; Lass-Flörl C; Kofler G; Nagl M; Borg-von Zepelin M; Dierich MP; Würzner R
Immunobiology; 1999 Sep; 201(1):133-44. PubMed ID: 10532286
[TBL] [Abstract][Full Text] [Related]
17. Yeast ATP-binding cassette transporters conferring multidrug resistance.
Prasad R; Goffeau A
Annu Rev Microbiol; 2012; 66():39-63. PubMed ID: 22703054
[TBL] [Abstract][Full Text] [Related]
18. Atomic modelling and systematic mutagenesis identify residues in multiple drug binding sites that are essential for drug resistance in the major Candida transporter Cdr1.
Nim S; Lobato LG; Moreno A; Chaptal V; Rawal MK; Falson P; Prasad R
Biochim Biophys Acta; 2016 Nov; 1858(11):2858-2870. PubMed ID: 27569110
[TBL] [Abstract][Full Text] [Related]
19. Triangular gold nanoparticles conjugated with peptide ligands: a new class of inhibitor for Candida albicans secreted aspartyl proteinase.
Jebali A; Hajjar FH; Hekmatimoghaddam S; Kazemi B; De La Fuente JM; Rashidi M
Biochem Pharmacol; 2014 Aug; 90(4):349-55. PubMed ID: 24887590
[TBL] [Abstract][Full Text] [Related]
20. The ABCs of Candida albicans Multidrug Transporter Cdr1.
Prasad R; Banerjee A; Khandelwal NK; Dhamgaye S
Eukaryot Cell; 2015 Dec; 14(12):1154-64. PubMed ID: 26407965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
